Treatment of hypertension with olmesartan medoxomil, alone and in combination with a diuretic: an update
Author:
Publisher
Springer Science and Business Media LLC
Subject
Internal Medicine
Link
http://www.nature.com/articles/1002241.pdf
Reference70 articles.
1. Neutel JM . Clinical studies of CS-866, the newest angiotensin II receptor antagonist. Am J Cardiol 2001; 87 (8A): 37C–43C.
2. Chrysant SG, Chrysant GS . Antihypertensive efficacy of olmesartan medoxomil alone and in combination with hydrochlorothiazide. Expert Opin Pharmacother 2004; 5: 657–667.
3. Puchler K, Laeis P, Stumpe KO . Blood pressure response, but not adverse event incidence correlates with dose of angiotensin II antagonist. J Hypertens 2001; 19 (Suppl 1): S41–S48.
4. Neutel JM, Elliott WJ, Izzo JL, Chen CL, Masonson HN . Antihypertensive efficacy of olmesartan medoxomil, a new angiotensin II receptor antagonist, assessed by ambulatory blood pressure measurements. J Clin Hypertens 2002; 4: 325–331.
5. Brunner HR, Nussberger J . Relevance of clinical pharmacological models for the evaluation of therapeutic dose range of an AT1 receptor antagonist. J Hypertens 2001; 19 (Suppl 1): S15–S20.
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Sustained release olmesartan medoxomil loaded PLGA nanoparticles with improved oral bioavailability to treat hypertension;Journal of Drug Delivery Science and Technology;2020-02
2. Development of efficient one-pot three-component assembly of trityl olmesartan medoxomil;Bioorganic & Medicinal Chemistry;2018-08
3. The relative bioavailability and fasting pharmacokinetics of three formulations of olmesartan medoxomil 20-mg capsules and tablets in healthy Chinese male volunteers: An open-label, randomized-sequence, single-dose, three-way crossover study;Clinical Therapeutics;2010-08
4. Blood Pressure-Lowering Effects of Angiotensin Receptor Antagonist Monotherapy and in Combination with Other Anti-Hypertensive Drugs in Primary Care Settings in Japan;Clinical and Experimental Hypertension;2009-01
5. Amlodipine/ARB fixed-dose combinations for the treatment of hypertension: Focus on amlodipine/olmesartan combination;Drugs of Today;2008
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3